Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

Moses Rodriguez, Daniel R. Wynn, Teresa K. Kimlinger, Jerry A. Katzmann

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We noted no differences in CSF C9 or C9 index between patients with multiple sclerosis and neurologic controls.

Original languageEnglish (US)
Pages (from-to)855-857
Number of pages3
JournalNeurology
Volume40
Issue number5
DOIs
StatePublished - May 1990

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls'. Together they form a unique fingerprint.

  • Cite this